Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping review.

M MonaghanM RizkS PilonA IyengarR ShorrJ TayD MazeC BredesonB HuttonDavid S Allan

Published in: Transfusion medicine (Oxford, England) (2018)

More RCTs that enrol greater numbers of similar patients are needed to leverage the current evidence network concerning donor choice and source of cells used in allogeneic HCT.

Keyphrases

stem cell transplantation
end stage renal disease
bone marrow
cell cycle arrest
newly diagnosed
ejection fraction
induced apoptosis
chronic kidney disease
peritoneal dialysis
high dose
low dose
mesenchymal stem cells
patient reported outcomes
patient reported
cell therapy